Learn each class by mechanism and the signature adverse effect, then match drugs with comorbidities.
Drug classes
- Metformin: lowers hepatic gluconeogenesis; GI upset, lactic acidosis, vitamin B12 deficiency; no hypoglycemia, weight neutral.
- Sulfonylureas: close K-ATP channels, stimulate insulin release; hypoglycemia and weight gain.
- Thiazolidinediones (pioglitazone): PPAR-gamma; fluid retention, heart failure, fractures.
- DPP-4 inhibitors: increase incretins; pancreatitis risk.
- GLP-1 agonists: weight loss, cardiovascular benefit; nausea, pancreatitis, thyroid C-cell tumor warning.
- SGLT2 inhibitors: glucosuria; genital yeast infections, euglycemic ketoacidosis, benefit in heart failure and kidney disease.
Choosing
Pick GLP-1 agonists or SGLT2 inhibitors for atherosclerotic disease, heart failure or chronic kidney disease. Insulin is used for type 1, pregnancy and severe hyperglycemia.
Keep going in endocrinology and diabetes
- Hypothyroidism and Hashimoto thyroiditis
- Hyperthyroidism: Graves disease, thyroiditis and thyroid storm
- Thyroid nodules and thyroid cancer types
- Cushing syndrome and adrenal insufficiency